These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 33470396)
21. Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Singh MM; Johnson B; Venkatarayan A; Flores ER; Zhang J; Su X; Barton M; Lang F; Chandra J Neuro Oncol; 2015 Nov; 17(11):1463-73. PubMed ID: 25795306 [TBL] [Abstract][Full Text] [Related]
22. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors. Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888 [TBL] [Abstract][Full Text] [Related]
23. Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA. Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C Biomed Res Int; 2018; 2018():4246703. PubMed ID: 30356407 [TBL] [Abstract][Full Text] [Related]
24. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma. Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940 [TBL] [Abstract][Full Text] [Related]
25. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer. Laufer-Amorim R; Fonseca-Alves CE; Villacis RAR; Linde SAD; Carvalho M; Larsen SJ; Marchi FA; Rogatto SR Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925701 [TBL] [Abstract][Full Text] [Related]
28. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups. Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882 [TBL] [Abstract][Full Text] [Related]
29. Expression and clinical significance of CPS1 in glioblastoma multiforme. Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588 [TBL] [Abstract][Full Text] [Related]
30. Specific patterns of DNA copy number gains and losses in eight new glioblastoma multiforme cell lines. Ramirez T; Thoma K; Taja-Chayeb L; Efferth T; Herrera LA; Halatsch ME; Gebhart E Int J Oncol; 2003 Aug; 23(2):453-60. PubMed ID: 12851695 [TBL] [Abstract][Full Text] [Related]
31. Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray. Wang L; Wei B; Hu G; Wang L; Bi M; Sun Z; Jin Y Mol Med Rep; 2015 Aug; 12(2):1991-6. PubMed ID: 25901754 [TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
34. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes. Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429 [TBL] [Abstract][Full Text] [Related]
35. Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma. Adilijiang A; Hirano M; Okuno Y; Aoki K; Ohka F; Maeda S; Tanahashi K; Motomura K; Shimizu H; Yamaguchi J; Wakabayashi T; Natsume A Molecules; 2019 Aug; 24(17):. PubMed ID: 31443404 [TBL] [Abstract][Full Text] [Related]
36. Bioinformatics analysis reveals disturbance mechanism of MAPK signaling pathway and cell cycle in Glioblastoma multiforme. Li W; Li K; Zhao L; Zou H Gene; 2014 Sep; 547(2):346-50. PubMed ID: 24967941 [TBL] [Abstract][Full Text] [Related]
37. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma. Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126 [TBL] [Abstract][Full Text] [Related]
38. Integrated genomic analysis of survival outliers in glioblastoma. Peng S; Dhruv H; Armstrong B; Salhia B; Legendre C; Kiefer J; Parks J; Virk S; Sloan AE; Ostrom QT; Barnholtz-Sloan JS; Tran NL; Berens ME Neuro Oncol; 2017 Jun; 19(6):833-844. PubMed ID: 27932423 [TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis of gene expression profiles to diagnose crucial and novel genes in glioblastoma multiform. Vastrad C; Vastrad B Pathol Res Pract; 2018 Sep; 214(9):1395-1461. PubMed ID: 30097214 [TBL] [Abstract][Full Text] [Related]
40. Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms. Zhang Y; Xia Q; Lin J Oncol Rep; 2018 Aug; 40(2):715-725. PubMed ID: 29901201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]